Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
There has been increased interest in the use of chloroquine and hydroxychloroquine in the context of COVID-19 which is currently under evaluation in trials. There are potential cardiovascular side effects associated with its use.
We have summarised output from ESC meetings and journals related to this below.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.